Car T-Cell Therapy in Children and Adults with Blood Cancers

Topics Covered

We invite you to learn more about:

• Who qualifies for CAR T-cell (chimeric antigen receptor T-cell) therapy 
• CAR T-cell therapy currently approved for children
• CAR T-cell therapy currently approved for adults 
• The future of CAR T-cell therapy for blood cancer patients

Speakers

Loretta Nastoupil, MD
Assistant Professor
Department of Lymphoma/Myeloma
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Rayne H. Rouce, MD
Assistant Professor
Department of Pediatrics
Texas Children’s Cancer Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX
 

Audio Replay

Program Materials

Program Support

Support for this program provided by Celgene, Kite, a Gilead Company and Novartis.

< Back to Webcasts